LongGame Ventures

About LongGame Ventures

LongGame is a venture capital firm, founded in 2024, dedicated to funding radical lifespan extension for everyone. It backs pre-seed and seed longevity biotech companies developing technologies that can significantly extend healthy human life and scale to benefit society as a whole, through its $40 million LongGame Fund I. Its portfolio spans drug discovery, gene therapy, cell therapy, senolytics, and tooling, including Vincere Bio, Adaptyv Bio, Telos Biotech, Ladder Bio, Cirrus Therapeutics, Repair Biotechnologies, Aperture Therapeutics, Deciduous, General Proximity, and Oisin Bio. The fund is also exploring decentralized science, including tokenized intellectual property and decentralized crowdfunding. Its hard rule is that every company must have the potential to extend healthy human lifespan by at least 10 years. LongGame prioritizes scalable solutions for global populations, not just the wealthy, and backs teams with strong ethical foundations and robust, credible scientific evidence that target aging at its root cause.
People
  • Manish Chamoli, Co-Founder & Managing Partner